# Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION)

> **NCT07739914** · PHASE3 · RECRUITING · sponsor: **Hannover Medical School** · enrollment: 150 (estimated)

## Conditions studied

- Liver Allograft
- Liver Diseases
- Liver Transplantation

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Tacrolimus or Cyclosporine

## Key facts

- **NCT ID:** NCT07739914
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-19
- **Primary completion:** 2029-06-30
- **Final completion:** 2031-06-30
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07739914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07739914, "Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07739914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*